New pathogens for respiratory infections

Roberto Cosentini, Francesco Blasi

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The emergence of new pathogens and the increasing antimicrobial resistance patterns of old pathogens are contributing factors to the high epidemiologic impact of lower respiratory tract infections. Hantaviruses, Chlamydia pneumoniae, and penicillin-resistant Streptococcus pneumoniae have recently gained most of the attention of international researchers. Hantavirus pulmonary syndrome has been confirmed in 100 cases with a very high mortality (52%). Risk factors for infection are peridomestic cleaning, agricultural activities, and an increased number of small rodents like deer mouse, mainly Peromyscus maniculatus. Pulmonary capillary leak and multiorgan involvement characterise Hantavirus pulmonary syndrome. Most recent reports rank C. pneumoniae among the three most common etiologic agents in community-acquired pneumonia, but it is also involved in chronic diseases such as chronic obstructive pulmonary disease and asthma. Several recent reports indicate the striking increase of penicillin-resistant S. pneumoniae strains. These data emphasize the crucial need for new therapeutic agents and more effective prevention programs.

Original languageEnglish
Pages (from-to)174-180
Number of pages7
JournalCurrent Opinion in Pulmonary Medicine
Volume2
Issue number3
Publication statusPublished - 1996

Fingerprint

Hantavirus Pulmonary Syndrome
Peromyscus
Chlamydophila pneumoniae
Streptococcus pneumoniae
Respiratory Tract Infections
Penicillins
Hantavirus
Chronic Obstructive Pulmonary Disease
Rodentia
Pneumonia
Chronic Disease
Asthma
Research Personnel
Lung
Mortality
Infection
Therapeutics

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

New pathogens for respiratory infections. / Cosentini, Roberto; Blasi, Francesco.

In: Current Opinion in Pulmonary Medicine, Vol. 2, No. 3, 1996, p. 174-180.

Research output: Contribution to journalArticle

Cosentini, Roberto ; Blasi, Francesco. / New pathogens for respiratory infections. In: Current Opinion in Pulmonary Medicine. 1996 ; Vol. 2, No. 3. pp. 174-180.
@article{24202d8b2362496eb3f69708afc605c9,
title = "New pathogens for respiratory infections",
abstract = "The emergence of new pathogens and the increasing antimicrobial resistance patterns of old pathogens are contributing factors to the high epidemiologic impact of lower respiratory tract infections. Hantaviruses, Chlamydia pneumoniae, and penicillin-resistant Streptococcus pneumoniae have recently gained most of the attention of international researchers. Hantavirus pulmonary syndrome has been confirmed in 100 cases with a very high mortality (52{\%}). Risk factors for infection are peridomestic cleaning, agricultural activities, and an increased number of small rodents like deer mouse, mainly Peromyscus maniculatus. Pulmonary capillary leak and multiorgan involvement characterise Hantavirus pulmonary syndrome. Most recent reports rank C. pneumoniae among the three most common etiologic agents in community-acquired pneumonia, but it is also involved in chronic diseases such as chronic obstructive pulmonary disease and asthma. Several recent reports indicate the striking increase of penicillin-resistant S. pneumoniae strains. These data emphasize the crucial need for new therapeutic agents and more effective prevention programs.",
author = "Roberto Cosentini and Francesco Blasi",
year = "1996",
language = "English",
volume = "2",
pages = "174--180",
journal = "Current Opinion in Pulmonary Medicine",
issn = "1070-5287",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - New pathogens for respiratory infections

AU - Cosentini, Roberto

AU - Blasi, Francesco

PY - 1996

Y1 - 1996

N2 - The emergence of new pathogens and the increasing antimicrobial resistance patterns of old pathogens are contributing factors to the high epidemiologic impact of lower respiratory tract infections. Hantaviruses, Chlamydia pneumoniae, and penicillin-resistant Streptococcus pneumoniae have recently gained most of the attention of international researchers. Hantavirus pulmonary syndrome has been confirmed in 100 cases with a very high mortality (52%). Risk factors for infection are peridomestic cleaning, agricultural activities, and an increased number of small rodents like deer mouse, mainly Peromyscus maniculatus. Pulmonary capillary leak and multiorgan involvement characterise Hantavirus pulmonary syndrome. Most recent reports rank C. pneumoniae among the three most common etiologic agents in community-acquired pneumonia, but it is also involved in chronic diseases such as chronic obstructive pulmonary disease and asthma. Several recent reports indicate the striking increase of penicillin-resistant S. pneumoniae strains. These data emphasize the crucial need for new therapeutic agents and more effective prevention programs.

AB - The emergence of new pathogens and the increasing antimicrobial resistance patterns of old pathogens are contributing factors to the high epidemiologic impact of lower respiratory tract infections. Hantaviruses, Chlamydia pneumoniae, and penicillin-resistant Streptococcus pneumoniae have recently gained most of the attention of international researchers. Hantavirus pulmonary syndrome has been confirmed in 100 cases with a very high mortality (52%). Risk factors for infection are peridomestic cleaning, agricultural activities, and an increased number of small rodents like deer mouse, mainly Peromyscus maniculatus. Pulmonary capillary leak and multiorgan involvement characterise Hantavirus pulmonary syndrome. Most recent reports rank C. pneumoniae among the three most common etiologic agents in community-acquired pneumonia, but it is also involved in chronic diseases such as chronic obstructive pulmonary disease and asthma. Several recent reports indicate the striking increase of penicillin-resistant S. pneumoniae strains. These data emphasize the crucial need for new therapeutic agents and more effective prevention programs.

UR - http://www.scopus.com/inward/record.url?scp=0030132798&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030132798&partnerID=8YFLogxK

M3 - Article

C2 - 9363136

AN - SCOPUS:0030132798

VL - 2

SP - 174

EP - 180

JO - Current Opinion in Pulmonary Medicine

JF - Current Opinion in Pulmonary Medicine

SN - 1070-5287

IS - 3

ER -